TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Blood Glucose and Ketones monitoring

Blood analysis services
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Doncaster and Bassetlaw Teaching Hospital NHS Foundation Trust: "Blood Glucose and Ketones monitoring". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityDoncaster and Bassetlaw Teaching Hospital NHS Foundation TrustScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: Doncaster and Bassetlaw Teaching Hospital NHS Foundation Trust
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for Doncaster and Bassetlaw Teaching Hospital NHS Foundation Trust. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
6Bids / Report
0% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 2 active published awards; 1 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityDoncaster and Bassetlaw Teaching Hospital NHS Foundation Trust
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published13 Nov 2023, 14:59 GMT
Last source update13 Nov 2023, 14:59 GMT
Recurring procurementNot published
ClassificationBlood analysis services
Delivery area
UK
OCIDocds-h6vhtk-0417d9
What is being bought
Blood Glucose and ketone monitoring including middle ware, stripes, training and maintainance
What changed
From the official release history
  1. Status changed to complete
    13 Nov 2023, 14:59 GMT
  2. Official notice release published
    13 Nov 2023, 14:59 GMT
  3. Buyer information updated
    13 Nov 2023, 14:59 GMT
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    Status not published
    Published valueNot published
    A direct award for this contract to Abbott will ensure business continuity for the POCT service and In-patient Diabetic Service within Doncaster and Bassetlaw Teaching Hospitals Foundation Trust (DBTH NHS FT). Due to the current contract, expiring (August 2023) there is insufficient time to complete a full tender process without compromising the current service, which poses a huge patient safety risk. The Abbott glucose and ketone meters are currently in use in approximately 105 clinical areas within DBTH NHS FT, with over 3000 members of staff trained to use the meter. Implementation of a new providers meter would require significant resources in market scoping, middleware procurement, manufacturing lead-time for providing meters, verification of meters, training the workforce, any required changes to patient pathways, consumable management and IT implementation and the resource required to facilitate this. <br/>The duration of the new contract will be for a three-year period from the point that the current contract ends and upto the point where a procurement exercise is undertaken and a new contract awarded. The duration has been determined so that the expiration aligns with other trusts contracts within the South Yorkshire and Bassetlaw Pathology (SYB Pathology) network. This gives the SYB network time to draft a region wide specification for a Glucose and Ketone Meter contract. This is the current planned strategy, however this is subject to change. The current plan is for SYB to move to a maturing status for the POCT service as per National NHS England guidance and this contract will enable preparation work and planning for this to be achieved. The proposed contract extension in the interim is to prevent significant risk from a service delivery and clinical perspective for the patient population of DBTH NHS FT.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    13 Nov 2023, 14:59 GMT
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 13 Nov 2023, 00:00 GMT · £650,000
Commercial outcome and competition
Awards
Abbott Laboratories Limited
Not published · Not published · active
Contracts
Contract
£650,000 · signed 13 Nov 2023, 00:00 GMT · active
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

Doncaster and Bassetlaw Teaching Hospital NHS Foundation Trust

Contracting authority GB-FTS-32789
View buyer profile

  • Doncaster and Bassetlaw Teaching Hospital NHS Foundation Trust
    buyer
    mediationBody
    reviewContactPoint

    Doncaster Royal Infirmary, Armthorpe Road, Doncaster, UKE31, DN2 5LT
    Amy.jones143@nhs.net
    +44 7768725233

  • Abbott Laboratories Limited
    supplier

    00329102
    Abbott House, Vanwall Road Vanwall Business Park Maidenhead, Maidenhead, UKK, SL6 4XE

  • The High Court
    reviewBody

    The Strand, London, WC2A 2LL
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleA direct award for this contract to Abbott will ensure business continuity for the POCT service and In-patient Diabetic Service within Doncaster and Bassetlaw Teaching Hospitals Foundation Trust (DBTH NHS FT). Due to the current contract, expiring (August 2023) there is insufficient time to complete a full tender process without compromising the current service, which poses a huge patient safety risk. The Abbott glucose and ketone meters are currently in use in approximately 105 clinical areas within DBTH NHS FT, with over 3000 members of staff trained to use the meter. Implementation of a new providers meter would require significant resources in market scoping, middleware procurement, manufacturing lead-time for providing meters, verification of meters, training the workforce, any required changes to patient pathways, consumable management and IT implementation and the resource required to facilitate this. <br/>The duration of the new contract will be for a three-year period from the point that the current contract ends and upto the point where a procurement exercise is undertaken and a new contract awarded. The duration has been determined so that the expiration aligns with other trusts contracts within the South Yorkshire and Bassetlaw Pathology (SYB Pathology) network. This gives the SYB network time to draft a region wide specification for a Glucose and Ketone Meter contract. This is the current planned strategy, however this is subject to change. The current plan is for SYB to move to a maturing status for the POCT service as per National NHS England guidance and this contract will enable preparation work and planning for this to be achieved. The proposed contract extension in the interim is to prevent significant risk from a service delivery and clinical perspective for the patient population of DBTH NHS FT.